Financial Daily from THE HINDU group of publications
Saturday, May 15, 2004
Financial Daily from THE HINDU group of publications Saturday, May 15, 2004 |
||
|
|
||
|
Corporate
-
Outlook Orchid Chem plans to sell Cefazolin in US Our Bureau
Chennai , May 14 ORCHID Chemicals & Pharmaceuticals on Friday announced that it had applied for permission in the US to sell Cefazolin, a formulation (finished drug), there. This is the company's first attempt to sell formulations in the US. A company press release said it had filed an Abbreviated New Drug Application (ANDA) with the US authorities for its injectable, Cefazolin. The company plans to file 15 applications in the current financial year, said the release. The formulation would be made in its plant located at Irungattukottai, near Chennai. In December 2003, the US Food and Drug Administration approved its bulk drug manufacturing facility for Cefazolin. The ANDA application is linked to Orchid's distribution deal with the Canada-based Apotex in 2003.
More Stories on : Outlook | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|